Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Valneva starts Phase ll trial of VLA15 to treat Lyme disease

Lyme disease is a systemic infection caused by Borrelia burgdorferi bacteria. Credit: National Institute of Allergy and Infectious Diseases, National Institutes of Health.

  • Lyme disease infection

Go Top